Search for a command to run...
<h3>Background and Importance</h3> The provision of dietetic products, including protein modules, oral nutritional supplements and enteral nutrition, from hospital pharmacy services to long-term care facilities (LTCFs) presents a logistical and economic challenge. Although dietetic support in LTCFs is essential, only few studies have quantified the economic benefits of pharmacist-led optimisation. <h3>Aim and Objectives</h3> To analyse dietetic products and thickeners dispensed in 2024 to eight affiliated private or publicly contracted LTCFs and to evaluate the economic impact of hospital pharmacist interventions in optimising orders and stock management. <h3>Material and Methods</h3> A retrospective observational study was conducted including all institutionalised patients receiving dietetic products and/or thickeners dispensed during 2024. The hospital pharmacist reviewed monthly active treatments and surplus stocks at each centre, resulting from hospital admissions, therapy modifications, transfers, or deaths. Subsequent orders were adjusted to promote stock rotation and prevent accumulation. Surplus products unfit for local use were reallocated to avoid expiry. Urgent deliveries due to new prescriptions were coordinated to prevent delays. Data were collected from outpatient dispensing records, order lists, and monthly stock reports. Dispensed units were analysed, and costs according to our regional centralised procurement framework were compared with their retail price (RP) in community pharmacies. The economic impact of pharmacist interventions was calculated based on avoided shipments, returns, and redistributions. <h3>Results</h3> 390 institutionalised patients received dietetic products and/or thickener and 249 remained on active therapy at year-end. A total of 105.084 units were dispensed at a cost of €191.355,73, compared with an estimated RP of €750.587,50, representing a 74,5% saving (€559.231,77). Most frequently dispensed products were high-protein, high-calorie oral nutritional supplements (57,27%), diabetes-specific supplements (19,03%), and renal-specific formulas (8,82%). Stock optimisation enabled the reallocation of 977 units (avoiding €9.021,17 RP) and prevented unnecessary dispensing of 21.961 surplus units (€155.448,07 RP), resulting in an additional saving of €164.469,24. Overall, the avoided expenditure attributable to pharmacist intervention reached €723.701,01, corresponding to a 79,1% reduction. <h3>Conclusion and Relevance</h3> Hospital pharmacy-led dispensing of dietetic products to LTCFs represents a successful model of integrated pharmaceutical care requiring close coordination between prescribers, pharmacists, LTCFs, and manufacturers. Integration of hospital pharmacists into the care process optimised resources, reduced costs, prevented product expiry, and maintained nutritional therapy continuity. <h3>Conflict of Interest</h3> No conflict of interest